Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Significant Components of Net Deferred Tax Assets (Detail)

v3.24.1
Income Taxes - Schedule of Significant Components of Net Deferred Tax Assets (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets    
Net operating loss carryforward $ 58,843 $ 53,957
Interest 304 0
Research and development credits 16,630 15,235
Deferred stock compensation 6,982 8,086
Deferred revenue 2,641 16,127
Lease liability 3,561 4,516
Accrued expenses and other 415 1,846
Depreciable and amortizable assets 126  
Capitalized Research & Experimental Expenditures 26,268 19,764
Total deferred tax assets 115,770 119,531
Total deferred tax liabilities    
Depreciable and amortizable assets   (1,329)
Right-of-use asset (2,668) (3,488)
Notes payable - CVR (716)  
Total deferred tax liabilities (3,384) (4,817)
Less: Valuation allowance (112,386) (114,714)
Net deferred tax assets $ 0 $ 0